Next Article in Journal
Automated Uterine Fibroids Detection in Ultrasound Images Using Deep Convolutional Neural Networks
Previous Article in Journal
Effectiveness of the Boston Brace in the Treatment of Paediatric Scoliosis: A Longitudinal Study from 2010–2020 in a National Spinal Centre
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Healthcare
Volume 11
Issue 10
10.3390/healthcare11101492
healthcare-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sleep Quality in Women with Premenstrual Syndrome Is Associated with Metabolic Syndrome-Related Variables

by
Hyejin Chun
1 and
Miae Doo
2,*
1
Department of Family Medicine, Ewha Womans University College of Medicine, Seoul 07804, Republic of Korea
2
Department of Food and Nutrition, Kunsan National University, Gunsan 54150, Republic of Korea
*
Author to whom correspondence should be addressed.
Healthcare 2023, 11(10), 1492; https://doi.org/10.3390/healthcare11101492
Submission received: 16 March 2023 / Revised: 3 May 2023 / Accepted: 18 May 2023 / Published: 20 May 2023
Browse Figures
Review Reports Versions Notes

Abstract

:
In this study, we examined whether metabolic syndrome (MetS)-related variables are simultaneously affected by sleep quality, premenstrual syndrome (PMS) and dietary consumption. In this cross-sectional study, data for 307 premenopausal women were available. The results showed that women experiencing PMS had significantly lower sleep quality and were more depressed and anxious (p < 0.001 for all). After the subjects were divided into groups according to PMS, the effect of sleep quality on MetS-related variables or MetS components significantly differed; only among women who experienced PMS were poor sleepers significantly higher in waist circumference (p = 0.018) and diastolic blood pressure (p = 0.012) than good sleepers. Among the MetS components, abdominal obesity in women with poor sleep quality was approximately three (16.9% vs. 3.0%, p= 0.020) times more common than in those with good sleep quality. However, these findings were not observed among those who did not experience PMS. Poor sleepers among women experiencing PMS consumed 2.8 times more alcoholic drinks than good sleepers (p = 0.006). The MetS-related variables in Korean women experiencing PMS are associated with sleep quality, and these associations may be modified by dietary habits.

1. Introduction

Premenstrual syndrome (PMS) is characterized by a combination of somatic and psychological symptoms that occur during the luteal phase of the menstrual period, with symptoms ending after menstruation [1]. The symptoms of PMS include depression, anxiety, irritability, edema, social isolation, abdominal cramps, appetite changes and sleep problems [2]. The symptoms vary among different individuals; many women experience their periods with mild symptoms or without any symptoms at all. Some patients suffer severe PMS symptoms, which is indicative of a condition called premenstrual dysphoric disorder (PMDD) [3].
Many studies have reported that PMS in women is associated with health-related factors. One of the main causes of sleep problems in women of childbearing age is PMS, which results in insomnia, short sleep duration, daytime sleepiness and frequent nighttime awakenings [4,5]. A recent meta-analysis reported that alcohol consumption has a harmful effect on PMS [6]. Indeed, dietary consumption is associated with the presence or severity of PMS. For example, high consumption of fat, fast foods, fried foods, red meats and soft drinks or low consumption of fruits and vegetables were associated with the presence and increased severity of PMS [7,8,9]. Moreover, high consumption of fat, especially saturated fats, was positively associated with the symptoms of PMS [10]. Women who consume a high-fat diet have increased levels of estrogen, which results in the presence of symptoms such as breast swelling and tenderness, bloating, nodularity and water retention [11].
Metabolic syndrome (MetS) is a complex disorder that is defined by a cluster of factors: central obesity, hypertriglyceridemia, low HDL cholesterol, increased blood pressure and impaired blood glucose. MetS and its components are associated with an increased risk of cardiovascular disease, which is one of the leading causes of morbidity and mortality worldwide [12]. Risk factors that predispose individuals to MetS are components of unhealthy lifestyles, including dietary patterns, drinking, smoking, sleep behavior and physical activity, as well as genetic factors [13]. Thus, the management of MetS requires healthy lifestyle modifications.
Although there is no consensus to date that the presence of PMS directly affects MetS, one study has demonstrated that Iranian women with PMS had a significantly increased risk of MetS [14]. Additionally, some studies have reported that women who experienced obesity showed higher concentrations of TGs, lower HDL cholesterol [14], increased abdominal obesity [15] and increased risk for hypertension [16], which are components of MetS.
Therefore, we hypothesized that women who experienced PMS might have different MetS-related variables, since PMS affects sleep quality. Accordingly, the purpose of our study was to identify how MetS-related variables are affected by different levels of sleep quality and the presence of PMS among Korean women. In addition, dietary consumption was investigated according to different levels of sleep quality and the presence of PMS.

2. Subjects and Methods

2.1. Study Design and Subject Selection

The subjects in this cross-sectional study were premenopausal women who visited the hospital for health check-ups from September 2020 to June 2021. Before participating in the survey, among women who wanted to participate voluntarily, we asked if they met the following inclusion criteria: (1) having a regular menstrual cycle; (2) not having pregnant or breastfeeding status; (3) not having depression or anxiety and (4) not having sleep disorders (Figure 1). A total of 341 subjects satisfied the criteria and were included. We conducted a comprehensive face-to-face interview and assessed the anthropometric and laboratory variables of the subjects. Through subsequent hormone tests, we excluded subjects who experienced menopause or irregular menstrual cycles due to polycystic ovary syndrome or prolactinoma (n = 11). Additionally, we excluded women taking antidepressants or anxiety medications (n = 4) and those taking sleep disorder medications (n = 7). Furthermore, subjects with missing or inadequate anthropometric and laboratory data for assessing MetS (n = 7) and those having implausible daily consumption (total energy consumption of ≤500 kcal or ≥3500 kcal) were excluded (n = 5). Finally, a total of 307 participants were included in the analyses. Informed consent was obtained from all participants, and the study was approved by the Institutional Review Board (IRB No. 1040117-201905-HR-004-02, IRB No. CHAMC 2020-07-005-002).

2.2. Data Collection

Data on the presence of PMS, sleep quality, general characteristics, metabolic syndrome-related variables and diet were collected from subjects. The data on the presence of PMS, sleep quality, general characteristics and dietary consumption were collected using a newly developed questionnaire. MetS-related variables were assessed using data from health examinations at the health care center. The premenopausal status of subjects was confirmed through the following hormone tests: serum estradiol, progesterone, sex hormone binding globulin (SHBG) and prolactin.
The questionnaire was composed to investigate data on socioeconomic variables (including age, educational level, occupation and marriage status), health-related variables (including current smoking, alcohol drinking, physical activity, as assessed by the international physical activity questionnaire, dietary supplement use, depression and anxiety), presence of PMS, sleep quality and dietary consumption.
PMS was assessed using the Menstrual Distress Questionnaire (MDQ) developed by Moos [17] and modified and supplemented by Kim [18]. Symptoms experienced at least 2 weeks before the onset of menstruation were included. It has 41 items and is composed of a 5-point scale, with higher scores indicating severe PMS. Using these media, the study subjects were divided into two groups: women who experienced PMS (n = 152) and those who did not experience PMS (n = 155).
Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) [19]. The PSQI consists of 19 items and comprises seven sleep quality scores, including perceived sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disturbances, use of sleeping medication and daytime dysfunction. The global PSQI score ranges from 0 to 21, with PSQI ≤ 5 indicating “good sleepers” and PSQI > 5 indicating “poor sleepers”.
Depression was assessed using the Center for Epidemiological Studies–Depression (CES-D) by Radloff [20]. It has 20 items, with higher scores indicating greater depressive symptoms. Anxiety was assessed using the State–Trait Anxiety Inventory [21]. It has 20 items for trait anxiety and state anxiety. Our study used ‘state anxiety’, which measures subjectively perceived tension and anxiety in specific situations and current mood states. Higher scores indicate greater anxiety.
Dietary consumption was determined with face-to-face interviews by trained dietitians using a single 24-h recall record method. The typical number of alcoholic drinks consumed was investigated. The dietary consumption data were analyzed using CAN Pro 5.0 (computer-aided nutritional analysis program for professionals, Seoul, Republic of Korea) software, a nutrient database developed by the Korean Nutrition Society. Then, they were converted to dietary nutrient density, which is the amount of nutrients contained in 1000 kcal of specific nutrient consumption. Additionally, the obtained food items were categorized into food groups based on common food groups classified in the Korean Nutrient Database [22].
MetS-related variables included waist circumference (WC) and BP (blood pressure), including systolic blood pressure (SBP) and diastolic blood pressure (DBP), FG (fasting glucose), TG (triglyceride) and HDL-C (high-density lipoprotein cholesterol). MetS was defined based on the US National Cholesterol Education Program/Adult Treatment Panel III (NCEP/ATP III) [23] criteria of ≥3 of 5 of the following risk factors: (1) abdominal obesity, indicated by a WC of ≥85 cm according to the Korean Society for the Study of Obesity [24]; (2) high triglyceridemia, indicated by TGs ≥150 mg/dL or receiving treatment for high TGs; (3) low HDL-C (<50 mg/dL) or receiving treatment for low HDL-C; (4) high BP (≥130/85 mmHg) or receiving treatment for high BP and (5) high FG (≥100 mg/dL) or under treatment for high blood glucose.

2.3. Statistical Analyses

Tests of normality for all continuous variables were carried out before the analyses, and skewed variables were logarithmically transformed. Data are presented as back-transformed means and 95% confidence intervals (CIs). To assess general characteristics, including socioeconomic variables and health-related variables according to the presence of PMS, independent t tests were used for continuous variables, and Pearson’s χ2 test or Fisher’s exact test was used for categorical variables. After subjects were divided according to the presence of PMS, a general linear model was used to confirm the effects of sleep quality on metabolic syndrome-related variables and dietary nutrient density adjusted for depression level and anxiety level. A multivariate logistic regression adjusting for depression and anxiety levels was analyzed for the prevalence of metabolic syndrome and its components by sleep quality and presence of PMS. Differences in food groups per 1000 kcal according to sleep quality and the presence of PMS were analyzed using a general linear model after adjusting for depression level and anxiety level. A p value of <0.05 was considered to indicate statistical significance. All statistical analyses were performed using SPSS (version 27.0; IBM Corp., Armonk, NY, USA) software for Windows.

3. Results

The general characteristics dichotomized by the presence of premenstrual syndrome are shown in Table 1. The average age and sleep quality score measured using the PSQI were 39.58 years and 5.38, respectively. No significant differences in socioeconomic variables such as age, educational level, occupation and marriage status were found according to the presence of PMS. Among health-related variables, sleep quality, depression level and anxiety level were significantly higher in subjects who experienced PMS than in subjects who did not experience PMS (p < 0.001 for all). However, current smoking, alcohol drinking, physical activity by IPAQ and dietary supplementary intake were not significantly different according to the presence of PMS.
After the subjects were divided into groups according to the presence of PMS, to identify whether sleep quality affected MetS-related variables, a general linear model was used after adjusting for depression level and anxiety level (Table 2). Within the group that experienced PMS, subjects with poor sleep quality had significantly higher WC (74.10 cm vs. 70.36 cm, p = 0.018) and DBP (72.99 mmHg vs. 67.95 mmHg, p = 0.012) than those with good sleep quality. However, among groups who did not experience PMS, no significant differences were observed in WC and DBP according to sleep quality. Regardless of the experience of PMS, SBP, FG, TG and HDL-C did not differ with sleep quality.
The prevalence of MetS and its components according to sleep quality and the presence of PMS are listed in Figure 2. After controlling for covariates, a multivariate logistic regression model was used for the differences in the prevalence of MetS and its components according to sleep quality and the presence of PMS. The influence of PMS differences on the prevalence of MetS and its components were observed. In other words, within the group of subjects who experienced PMS, subjects with poor sleep showed a higher trend in the prevalence of MetS and its components than those with good sleep, regardless of statistical significance. On the other hand, trends according to sleep quality were difficult to find among those who did not experience PMS. Among the MetS components in subjects with poor sleep quality with PMS, abdominal obesity was approximately five times more common than in those with good sleep quality and without PMS (16.9% vs. 3.0%, p = 0.020).
After being stratified into groups according to the presence of PMS, the consumption of nutrients and food groups according to sleep quality are represented in Table 3 and Table 4, respectively. Dietary nutrient density was calculated as the ratio of nutrients to calories consumed. There were no significant differences between all dietary nutrient densities and sleep quality, regardless of the presence of PMS. Differences in the consumption of food groups per 1000 kcal were observed between subgroups of sleep quality and the presence of PMS (Table 4). Among subjects who did not experience PMS, milk and dairy products were consumed approximately 2 times more often by good sleepers than by poor sleepers (57.56 g vs. 28.84 g, p = 0.020). Different trends were identified in subjects who experienced PMS. In other words, among subjects who experienced PMS, subjects with good sleep showed significantly higher consumption of eggs than those with poor sleep (29.39 g vs. 16.69 g, p = 0.028). However, alcoholic drinks were consumed less by good sleepers than by poor sleepers (24.9 g vs. 70.9 g, p = 0.006).

4. Discussion

The aim of this study was to examine whether sleep quality influenced MetS-related variables or dietary consumption in relation to the presence of PMS in a community-based cross-sectional study conducted on 307 Korean women. When stratified by the presence of PMS in a model that adjusted for depression level and anxiety level, the MetS-related variables and prevalence of MetS components according to sleep quality were significantly different. Additionally, the consumption of food groups showed significant differences in good and poor sleep quality after being divided into groups according to the presence of PMS.
The findings of our study are consistent with those of previous studies [4,5,25,26]. Women with PMS suffer more psychological abnormalities, such as symptoms of depression, anxiety, irritability and poor sleep quality. These are also some of the many symptoms that appear as PMS. Meers et al. reported that sleep deprivation and psychological abnormalities co-occurred, rather than existing as separate correlated factors associated with the severity of PMS and negative mood [26]. Although the cause of PMS has not been clearly defined as one of the explanatory factors, hormonal imbalance is associated with the presence or severity of PMS. A study of women with diagnosed PMDD reported that a sudden reproductive hormone (estradiol and progesterone) change was responsible for triggering negative mood or poor sleep [27]. Metabolic syndrome-related variables and the prevalence of MetS and its components according to the presence of PMS were not observed. Accordingly, we stratified the participants into groups according to the presence of PMS, and then a general linear model or multivariate logistic regression model was used to determine whether sleep quality affected the metabolic syndrome-related variables and the prevalence of MetS and its components after adjusting for depression and anxiety levels. In this study, it was demonstrated that increased waist circumference and central adiposity were present in more poor-quality sleepers than good-quality sleepers among women who experienced PMS. However, these results according to sleep quality were not shown among the women who experienced PMS. As noted in our results, women with PMS showed more psychological disorders. These negative moods might result in abnormal dietary behaviors, such as premenstrual food craving, emotional eating and appetite for specific tastes or foods [28], which could result in obesity, especially central adiposity [15,28]. Additionally, as mentioned in our previous study, sleep patterns were associated with increased dietary consumption and changes in hormone levels, which could lead to obesity [29]. Recent studies have shown that sleep quality is a crucial determinant of the development of MetS [30,31]. It is well known that high blood pressure or triglycerides are associated with adiposity, depression or anxiety and sleep disorders. Our results are similar to those of previous studies [16,32,33] that reported an association of premenstrual syndrome with blood pressure and suggested that premenstrual syndrome might be related to the future subsequent development of high blood pressure. In particular, increased diastolic blood pressure, as seen in our results, has been recognized as a powerful predictor of future risk of cardiovascular disease among women under the age of 50. An increased prevalence of triglyceridemia linked to sleep quality was observed among women with PMS in our study. As expected, sleep quality and PMS were associated with increased triglyceridemia. However, to explain the exact mechanism, future studies will be needed to analyze the combined effect of sleep quality and PMS on increased triglyceridemia.
According to several studies [6,7,8,9,10] on the relationship between PMS and dietary factors, dietary management is important as a modifiable parameter to prevent the presence of PMS or alleviate the severity of PMS. Additionally, dietary patterns that increase abdominal adiposity, such as higher consumption of calories or foods containing simple sugars, are well recognized to be associated with inadequate sleep patterns [29,34]. Although this study showed no significant differences in dietary nutrient density according to sleep quality regardless of the presence of PMS, the consumption of food groups was shown according to be linked to sleep quality and the presence of PMS. However, among subjects who experienced premenstrual syndrome, the consumption of alcohol in poor sleepers was 2.44 times higher than that in good sleepers in our study. Heavy consumption of alcohol might increase the burden of sleep quality as well as symptoms of PMS. Alcohol use was suggested to trigger negative moods, such as depression, anxiety and abnormal metabolic variables. In contrast, the consumption of eggs in poor sleepers was 1.75 times lower than that in good sleepers among subjects who experienced PMS. Additionally, the consumption of milk and dairy products in poor sleepers was 1.75 times lower than that in good sleepers (2.04 times lower) among subjects who did not experience PMS. For the dietary management of PMS, excessive consumption of total carbohydrates, total saturated fat and sodium and poor consumption of calcium, magnesium, zinc, thiamine, riboflavin, vitamin B6, vitamin D and vitamin E have been reported [6,7,8,9,10]. Eggs, milk and dairy products provide protein of high biological value, unsaturated fatty acids, a variety of minerals (calcium, phosphorus, potassium and choline) and fat-soluble and B vitamins [35,36]. The intake of these foods was suggested to have a potentially protective effect on MetS-related variables. However, the findings of our study on the effect of specific foods and nutrients on PMS could not be concluded due to insufficient scientific evidence, in addition to that of previous studies [37]. PMS was influenced by a complex of various factors other than food or nutrition. Therefore, self-care methods for PMS management and personalized nutrition treatment by specialists should be provided to reduce the severity of PMS [37]. Our cross-sectional study results should be interpreted cautiously because they cannot be used to identify causal relationships and can only be used for estimated associations. A limitation of our study is that the subjects were Korean women, so our findings are difficult to generalize to women from other countries. In addition, the presence of PMS was assessed using a self-report questionnaire, thereby making it difficult to identify the severity of PMS.

5. Conclusions

Using 307 premenopausal women in a cross-sectional study, our study demonstrated that the presence of PMS is related to different negative moods, such as depression and anxiety, and sleep quality. Poor sleep quality was associated with abnormal MetS-related variables and undesirable dietary consumption in women who experienced PMS but not in those who did not experience PMS. These findings suggest that the risk of MetS-related variables in Korean women experiencing PMS is associated with sleep quality, and these associations are likely modulated by psychological management and dietary control.

Author Contributions

Conceptualization and methodology, M.D. and H.C.; formal analysis, M.D.; investigation, M.D. and H.C.; data curation, M.D. and H.C.; writing—original draft preparation, H.C.; writing—review and editing, M.D. and H.C.; supervision, M.D.; project administration, M.D.; funding acquisition, M.D. All authors have read and agreed to the published version of the manuscript.

Funding

This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science (NRF-2019R1C1C1002149).

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board of Kunsan National University and CHA Bundang Medical Center (protocol code: IRB No. 1040117-201905-HR-004-02, IRB No. CHAMC 2020-07-005-002).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data used in this study are not available to the public due to ethical considerations.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Johnson, S.R. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: A clinical primer for practitioners. Obstet. Gynecol. 2004, 104, 845–859. [Google Scholar] [CrossRef]
  2. American College of Obstetricians and Gynecologists. FAQs Premenstrual Syndrome (PMS). Available online: https://www.acog.org (accessed on 3 March 2023).
  3. Hardy, C.; Hunter, M.S. Premenstrual Symptoms and Work: Exploring Female Staff Experiences and Recommendations for Workplaces. Int. J. Environ. Res. Public Health 2021, 18, 3647. [Google Scholar] [CrossRef] [PubMed]
  4. Jehan, S.; Auguste, E.; Hussain, M.; Pandi-Perumal, S.R.; Brzezinski, A.; Gupta, R.; Attarian, H.; Jean-Louis, G.; McFarlane, S.I. Sleep and Premenstrual Syndrome. J. Sleep Med. Disord. 2016, 3, 1061. [Google Scholar]
  5. Conzatti, M.; Perez, A.V.; Maciel, R.F.; De Castro, D.H.; Sbaraini, M.; Wender, M.C.O. Sleep quality and excessive daytime sleepiness in women with Premenstrual Syndrome. Gynecol. Endocrinol. 2021, 37, 945–949. [Google Scholar] [CrossRef]
  6. Fernández, M.D.M.; Saulyte, J.; Inskip, H.M.; Takkouche, B. Premenstrual syndrome and alcohol consumption: A systematic review and meta-analysis. BMJ Open 2018, 8, e019490. [Google Scholar] [CrossRef] [PubMed]
  7. Isgin-Atici, K.; Kanbur, N.; Akgül, S.; Buyuktuncer, Z. Diet quality in adolescents with premenstrual syndrome: A cross-sectional study. Nutr. Diet. 2020, 77, 351–358. [Google Scholar] [CrossRef]
  8. Hashim, M.S.; Obaideen, A.A.; Jahrami, H.A.; Radwan, H.; Hamad, H.J.; Owais, A.A.; Alardah, L.G.; Qiblawi, S.; Al-Yateem, N.; Faris, M.A.E. Premenstrual syndrome is associated with dietary and lifestyle behaviors among university students: A cross-sectional study from Sharjah, UAE. Nutrients 2019, 11, 1939. [Google Scholar] [CrossRef] [PubMed]
  9. Farasati, N.; Siassi, F.; Koohdani, F.; Qorbani, M.; Abashzadeh, K.; Sotoudeh, G. Western dietary pattern is related to premenstrual syndrome: A case-control study. Br. J. Nutr. 2015, 114, 2016–2021. [Google Scholar] [CrossRef] [PubMed]
  10. Nagata, C.; Hirokawa, K.; Shimizu, N.; Shimizu, H. Soy, fat and other dietary factors in relation to premenstrual symptoms in Japanese women. BJOG 2004, 111, 594–599. [Google Scholar] [CrossRef]
  11. Wu, A.H.; Pike, M.C.; Stram, D.O. Meta-analysis: Dietary fat intake, serum estrogen levels, and the risk of breast cancer. J. Natl. Cancer Inst. 1999, 91, 529–534. [Google Scholar] [CrossRef]
  12. Fahed, G.; Aoun, L.; Zerdan, M.B.; Allam, S.; Zerdan, M.B.; Bouferraa, Y.; Assi, H.I. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. Int. J. Mol. Sci. 2022, 23, 786. [Google Scholar] [CrossRef]
  13. Saklayen, M.G. The Global Epidemic of the Metabolic Syndrome. Curr. Hypertens. Rep. 2018, 20, 12. [Google Scholar] [CrossRef] [PubMed]
  14. Hashemi, S.; Ramezan, I.; Tehrani, F.; Mohammadi, N.; Dovom, M.R.; Torkestani, F.; Simbar, M.; Azizi, F. Comparison of Metabolic and Hormonal Profiles of Women with and without Premenstrual Syndrome: A Community Based Cross-Sectional Study. Int. J. Endocrinol. Metab. 2016, 14, e28422. [Google Scholar] [CrossRef]
  15. Dang, N.; Khalil, D.; Sun, J.; Naveed, A.; Soumare, F.; Hamidovic, A. Waist Circumference and Its Association with Premenstrual Food Craving: The PHASE Longitudinal Study. Front. Psychiatry 2022, 13, 784316. [Google Scholar] [CrossRef] [PubMed]
  16. Xu, H.; Li, P.H.; Barrow, T.M.; Colicino, E.; Li, C.; Song, R.; Liu, H.; Tang, N.J.; Liu, S.; Guo, L.; et al. Obesity as an effect modifier of the association between menstrual abnormalities and hypertension in young adult women: Results from Project ELEFANT. PLoS ONE 2018, 13, e0207929. [Google Scholar] [CrossRef] [PubMed]
  17. Moos, R.H. The Development of a Menstrual Distress Questionnaire. Psychosom. Med. 1968, 30, 853–867. [Google Scholar] [CrossRef]
  18. Kim, S.J.; Han, C.J. Effects of Isoflavone and Cynanchum wilfordii Supplementation on Premenstrual Syndrome, Dysmenorrhea—Focus on 20’s Women. East Asian Soc. Diet. Life 2015, 25, 64–72. [Google Scholar] [CrossRef]
  19. Buysse, D.J.; Reynolds, C.F.; Monk, T.H.; Berman, S.R.; Kupfer, D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28, 193–213. [Google Scholar] [CrossRef]
  20. Radloff, L.S. The CES-D scale: A self report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 1, 385–401. [Google Scholar] [CrossRef]
  21. Spielberger, C.D.; Gorsuch, R.L.; Lushene, R.; Vagg, P.R.; Jacobs, G.A. Manual for the State-Trait Anxiety Inventory; Consulting Psychologists Press: Palo Alto, CA, USA, 1993. [Google Scholar]
  22. Ministry of Health and Welfare; The Korean Nutrition Society. Dietary Reference Intakes for Koreans 2020; The Korean Nutrition Society: Seoul, Republic of Korea, 2020. [Google Scholar]
  23. Expert Panel on Detection, Evaluation. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001, 285, 2486. [Google Scholar] [CrossRef]
  24. Yoon, Y.S.; Oh, S.W. Optimal waist circumference cutoff values for the diagnosis of abdominal obesity in Korean adults. Endocrinol. Metab. 2014, 29, 418–426. [Google Scholar] [CrossRef]
  25. Meers, J.M.; Nowakowski, S. Sleep, premenstrual mood disorder, and women’s health. Curr. Opin. Psychol. 2020, 34, 43–49. [Google Scholar] [CrossRef] [PubMed]
  26. Meers, J.M.; Bower, J.L.; Alfano, C.A. Poor sleep and emotion dysregulation mediate the association between depressive and premenstrual symptoms in young adult women. Arch. Womens Ment. Health 2020, 23, 351–359. [Google Scholar] [CrossRef] [PubMed]
  27. Schmidt, P.J.; Martinez, P.E.; Nieman, L.K.; Koziol, D.E.; Thompson, K.D.; Schenkel, L.; Wakim, P.G.; Rubinow, D.R. Premenstrual Dysphoric Disorder Symptoms Following Ovarian Suppression: Triggered by Change in Ovarian Steroid Levels but Not Continuous Stable Levels. Am. J. Psychiatry 2017, 174, 980–989. [Google Scholar] [CrossRef]
  28. Yen, J.Y.; Liu, T.L.; Chen, I.J.; Chen, S.Y.; Ko, C.H. Premenstrual appetite and emotional responses to foods among women with premenstrual dysphoric disorder. Appetite 2018, 125, 18–23. [Google Scholar] [CrossRef]
  29. Doo, M.; Kim, Y. Association between sleep duration and obesity is modified by dietary macronutrients intake in Korean. Obes. Res. Clin. Pract. 2016, 10, 424–431. [Google Scholar] [CrossRef]
  30. Kim, Y.J.; Yeom, H.E. Interactive Impact of Sleep Duration and Sleep Quality on the Risk of Developing Metabolic Syndrome in Korean Adults. Healthcare 2020, 8, 186. [Google Scholar] [CrossRef] [PubMed]
  31. Lian, Y.; Yuan, Q.; Wang, G.; Tang, F. Association between sleep quality and metabolic syndrome: A systematic review and meta-analysis. Psychiatry Res. 2019, 274, 66–74. [Google Scholar] [CrossRef] [PubMed]
  32. Bertone-Johnson, E.R.; Whitcomb, B.W.; Rich-Edwards, J.W.; Hankinson, S.E.; Manson, J.E. Premenstrual Syndrome and Subsequent Risk of Hypertension in a Prospective Study. Am. J. Epidemiol. 2015, 182, 1000–1009. [Google Scholar] [CrossRef]
  33. Bertone-Johnson, E.R.; Houghton, S.C.; Whitcomb, B.W.; Sievert, L.L.; Zagarins, S.E.; Ronnenberg, A.G. Association of Premenstrual Syndrome with Blood Pressure in Young Adult Women. J. Womens Health 2016, 25, 1122–1128. [Google Scholar] [CrossRef]
  34. Geiker, N.R.W.; Astrup, A.; Hjorth, M.F.; Sjödin, A.; Pijls, L.; Markus, C.R. Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa? Obes. Rev. 2018, 19, 81–97. [Google Scholar] [CrossRef] [PubMed]
  35. Sanlier, N.; Üstün, D. Egg consumption and health effects: A narrative review. J. Food Sci. 2021, 86, 4250–4261. [Google Scholar] [CrossRef]
  36. Marangoni, F.; Pellegrino, L.; Verduci, E.; Ghiselli, A.; Bernabei, R.; Calvani, R.; Cetin, I.; Giampietro, M.; Perticone, F.; Piretta, L.; et al. Cow’s Milk Consumption and Health: A Health Professional’s Guide. J. Am. Coll. Nutr. 2019, 38, 197–208. [Google Scholar] [CrossRef] [PubMed]
  37. Siminiuc, R.; Ţurcanu, D. Impact of nutritional diet therapy on premenstrual syndrome. Front. Nutr. 2023, 10, 1079417. [Google Scholar] [CrossRef] [PubMed]
Healthcare 11 01492 g001 550
Figure 1. Subject selection.
Figure 1. Subject selection.
Healthcare 11 01492 g001
Healthcare 11 01492 g002 550
Figure 2. Prevalence of metabolic syndrome and its components by sleep quality and presence of premenstrual syndrome. (A) Did not experience; (B) experienced. The data are expressed as %. * Differences in sleep quality and the presence of premenstrual syndrome were analyzed using multivariate logistic regression, adjusting for depression level and anxiety level.
Figure 2. Prevalence of metabolic syndrome and its components by sleep quality and presence of premenstrual syndrome. (A) Did not experience; (B) experienced. The data are expressed as %. * Differences in sleep quality and the presence of premenstrual syndrome were analyzed using multivariate logistic regression, adjusting for depression level and anxiety level.
Healthcare 11 01492 g002
Table
Table 1. General characteristics by presence of premenstrual syndrome.
Table 1. General characteristics by presence of premenstrual syndrome.
Did Not Experience
(n = 152)		Experienced
(n = 155)		p Value *
Age, years39.84 ± 5.87 (22–54)39.31 ± 6.94 (21–53)0.468
Educational level, ≥college90.185.80.294
Occupation, housewife24.332.30.131
Marriage status, yes80.980.60.533
Current smoking, no94.191.90.505
Alcohol drinking, no35.529.00.272
Physical activity by IPAQ, low46.144.50.566
Dietary supplementary intake, yes32.226.50.316
Sleep quality by PSQI4.45 ± 2.786.24 ± 2.82<0.001
Depression level28.54 ± 5.9834.88 ± 8.40<0.001
Anxiety level35.57 ± 7.9941.70 ± 8.52<0.001
The data are expressed as the mean ± SD or %; * Differences in the presence of premenstrual syndrome were analyzed using the χ2 test, Fisher’s exact test or the t test. Abbreviations: IPAQ, International Physical Activity Questionnaire; PSQI, Pittsburgh Sleep Quality Index.
Table
Table 2. Metabolic syndrome-related variables by sleep quality and presence of premenstrual syndrome.
Table 2. Metabolic syndrome-related variables by sleep quality and presence of premenstrual syndrome.
Did Not ExperienceExperienced
Good Sleeper (n = 114)Poor Sleeper (n = 38)p Value *Good Sleeper (n = 66)Poor Sleeper (n = 89)p Value *
WC (cm)72.38 ± 8.3370.66 ± 5.420.37270.36 ± 10.5974.10 ± 9.880.018
SBP (mmHg)114.63 ± 14.42114.84 ± 12.510.552112.55 ± 12.62115.16 ± 14.840.258
DBP (mmHg)69.69 ± 10.6271.63 ± 9.790.55967.95 ± 9.1271.99 ± 10.930.012
FG (mg/dL)94.18 ± 19.3695.92 ± 7.660.61190.64 ± 8.9392.93 ± 10.100.129
TG (mg/dL)88.43 ± 60.4374.92 ± 20.710.39878.58 ± 29.2390.51 ± 46.980.169
HDL-C (mg/dL)68.21 ± 15.7575.55 ± 15.650.09070.51 ± 16.8869.23 ± 18.480.891
The data are expressed as the mean ± 95% CI; * Differences in sleep quality and presence of premenstrual syndrome were analyzed using a general linear model after adjusting for depression level and anxiety level. Abbreviations: WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FG, fasting glucose; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol.
Table
Table 3. Dietary nutrient density by sleep quality and presence of premenstrual syndrome.
Table 3. Dietary nutrient density by sleep quality and presence of premenstrual syndrome.
Did Not ExperienceExperienced
Good Sleeper
(n = 114)		Poor Sleeper
(n = 38)		p Value *Good Sleeper
(n = 66)		Poor Sleeper
(n = 89)		p Value *
Carbohydrate (g)120.67 ± 23.78114.02 ± 28.18 0.131119.98 ± 25.25117.75 ± 29.580.789
Fat (g)34.70 ± 9.3035.91 ± 10.120.37635.81 ± 9.2834.69 ± 9.800.383
Protein (g)43.94 ± 11.8344.00 ± 11.160.88142.72 ± 8.5443.07 ± 10.280.795
Calcium (mg)272.56 ± 112.60249.30 ± 123.510.057259.79 ± 108.71260.22 ± 121.350.714
Phosphorus(mg)651.50 ± 174.15617.03 ± 160.970.209631.15 ± 130.75631.96 ± 160.830.755
Iron (mg)8.53 ± 3.418.42 ± 4.190.7217.82 ± 2.428.47 ± 3.710.117
Vitamin A (μg RAE)253.63 ± 146.56245.09 ± 126.840.458256.44 ± 133.94239.88 ± 139.440.714
Thiamin (mg)1.18 ± 0.431.17 ± 0.450.8631.17 ± 0.391.14 ± 0.450.431
Niacin (mg)9.25 ± 4.768.77 ± 5.070.6868.65 ± 3.288.20 ± 3.320.631
Folate (μg)285.59 ± 122.31303.21 ± 197.160.977310.10 ± 149.60278.98 ± 116.950.178
Vitamin C (mg)63.85 ± 61.7767.25 ± 84.430.98964.51 ± 54.6853.49 ± 45.960.322
The data are expressed as the mean ± SD; Dietary nutrient density (intake/1000 kcal); * Differences in sleep quality and presence of premenstrual syndrome were analyzed with a general linear model after adjusting for depression level and anxiety level.
Table
Table 4. Food groups per 1000 kcal by sleep quality and presence of premenstrual syndrome.
Table 4. Food groups per 1000 kcal by sleep quality and presence of premenstrual syndrome.
Did Not ExperienceExperienced
Good Sleeper (n = 114)Poor Sleeper (n = 38)p Value *Good Sleeper (n = 66)Poor Sleeper (n = 89)p Value *
Grains (g)110.76 ± 49.07
104.50 (84.12–130.50)		97.37 ± 41.02
89.61 (70.23–128.69)		0.133122.04 ± 56.52
113.64 (84.90–145.52)		108.33 ± 51.73
95.60 (76.89–129.91)		0.076
Sugar (g)5.32 ± 6.44
2.86 (1.19–7.02)		4.11 ± 4.17
3.46 (0.77–6.21)		0.1524.00 ± 4.09
2.92 (0.90–5.69)		4.77 ± 5.22
3.40 (1.46–6.30)		0.214
Soy and products (g)17.14 ± 33.25
4.61 (0.00–19.28)		9.89 ± 22.82
3.18 (0.00–9.08)		0.43120.89 ± 37.89
4.98 (0.00–25.54)		16.40 ± 35.31
2.59 (0.00–16.67)		0.449
Vegetables and mushrooms (g)159.47 ± 97.38
142.44 (100.43–201.37)		158.24 ± 71.92
160.25 (98.17–212.14)		0.494166.12 ± 108.77
153.84 (106.64–210.84)		156.24 ± 72.16
148.50 (102.01–206.58)		0.505
Fruits and products (g)110.30 ± 105.47
92.84 (16.47–161.43)		122.83 ± 127.68
94.48 (4.44–203.33)		0.757109.81 ± 116.13
80.19 (0.00–188.10)		110.70 ± 116.09
90.06 (0.00–163.82)		0.724
Meat (g)78.37 ± 52.70
73.26 (46.49–104.35)		94.93 ± 63.99
85.70 (45.56–137.53)		0.07271.90 ± 39.30
72.37 (49.46–100.19)		75.72 ± 44.99
74.30 (43.67–107.46)		0.787
Eggs (g)14.03 ± 21.84
0.00 (0.00–24.60)		18.90 ± 22.36
10.41 (0.00–31.79)		0.46629.39 ± 39.12
0.00 (0.00–43.71)		16.69 ± 28.14
0.00 (0.00–30.32)		0.028
Fish and shellfish (g)37.57 ± 50.43
9.06 (0.00–60.91)		40.35 ± 56.33
10.01 (0.00–65.30)		0.95032.44 ± 38.92
14.54 (0.00–60.72)		30.60 ± 40.41
9.18 (0.00–51.81)		0.773
Milk and dairy products(g)57.56 ± 75.98
0.00 (0.00–112.19)		28.84 ± 48.27
0.00 (0.00–53.97)		0.02043.16 ± 73.77
0.00 (0.00–80.21)		54.73 ± 91.18
0.00 (0.00–94.59)		0.345
Oil (g)4.61 ± 3.33
4.07 (2.10–6.18)		4.11 ± 3.10
3.58 (1.98–5.81)		0.1834.63 ± 3.58
3.98 (1.97–5.83)		4.05 ± 3.13
3.56 (1.46–6.21)		0.403
Seasoning (g)15.26 ± 9.02
15.06 (7.89–20.07)		15.40 ± 7.77
15.11 (9.07–20.13)		0.81713.99 ± 9.35
11.40 (7.74–19.99)		14.57 ± 8.91
13.58 (8.68–17.76)		0.663
Alcoholic drinks (g)40.91 ± 91.66
1.34 (0.00–37.40)		40.51 ± 110.34
0.15 (0.00–41.52)		0.91424.90 ± 42.00
0.00 (0.00–34.88)		70.19 ± 113.87
25.75 (0.00–106.55)		0.006
The data are expressed as the mean ± SD or median (interquartile range 25th–75th percentile); * Differences in sleep quality and the presence of premenstrual syndrome were analyzed with a general linear model after adjusting for depression level and anxiety level.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Chun, H.; Doo, M. Sleep Quality in Women with Premenstrual Syndrome Is Associated with Metabolic Syndrome-Related Variables. Healthcare 2023, 11, 1492. https://doi.org/10.3390/healthcare11101492

AMA Style

Chun H, Doo M. Sleep Quality in Women with Premenstrual Syndrome Is Associated with Metabolic Syndrome-Related Variables. Healthcare. 2023; 11(10):1492. https://doi.org/10.3390/healthcare11101492

Chicago/Turabian Style

Chun, Hyejin, and Miae Doo. 2023. "Sleep Quality in Women with Premenstrual Syndrome Is Associated with Metabolic Syndrome-Related Variables" Healthcare 11, no. 10: 1492. https://doi.org/10.3390/healthcare11101492

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop